Skip to search formSkip to main contentSkip to account menu

In Utero Drug Exposure

Exposure of the fetus to drugs that are used by the pregnant mother. It may affect fetal growth and result in withdrawal symptoms in the term infant.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
OBJECTIVE The goal of this study was to assess the current status of neonatal abstinence syndrome management from prenatal… 
2009
2009
A validated method for quantifying methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, cocaine, benzoylecgonine, 6… 
Review
2007
Review
2007
Drug use by pregnant women has been extensively associated with adverse mental, physical, and psychological outcomes in their… 
2007
2007
National drug policy, medical practice and the child welfare system have not kept pace with scientific research that points to… 
Review
2004
Review
2004
Scientifically valid data on the safety of drug use during pregnancy are a significant public health need. Data are rarely… 
Review
2002
Review
2002
1998
1998
Each year in the United States, around 5.5% (or 230,000) infants are born to mothers who used illicit drugs during pregnancy. The… 
1996
1996
We studied a cohort of 73 children exposed to cocaine in utero to characterize the spectrum of neurologic and ophthalmologic… 
Review
1994
Review
1994
Effects of in utero drug exposure on pregnancy outcome, infant development, and preschool functioning are reviewed. Six possible…